Feeds › Ownership stakes (13D / 13G)
Ownership stakes (13D / 13G)
Investors who own more than 5% of a company, from activists (13D) to passive holders (13G).
About this data
- What it is
- An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
- Who files it
- The investor, within days of crossing 5%, and again whenever the stake changes materially.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- 13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Filings per day, last 30 days
13D (activist) 13G (passive)
Latest ownership filings
Showing: ticker NNDM
| Filed | ScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders. | Company | Investor | Shares | % of shares | Filing |
|---|---|---|---|---|---|---|
| Oct 29, 2026 | SCHEDULE 13D/A (amended) | NNDM Nano Dimension Ltd. | Marc J. Bistricer | 20.42M | 10.1% | SCHEDULE 13D/A ↗ |
| Oct 29, 2026 | SCHEDULE 13D/A (amended) | NNDM Nano Dimension Ltd. | Clarendon Hugh Masters | 10.21M | 5.1% | SCHEDULE 13D/A ↗ |
| Oct 29, 2026 | SCHEDULE 13D/A (amended) | NNDM Nano Dimension Ltd. | Chaja Carlebach | 10.21M | 5.1% | SCHEDULE 13D/A ↗ |
| Oct 29, 2026 | SCHEDULE 13D/A (amended) | NNDM Nano Dimension Ltd. | Jason Jagessar | 10.21M | 5.1% | SCHEDULE 13D/A ↗ |
| Oct 29, 2026 | SCHEDULE 13D/A (amended) | NNDM Nano Dimension Ltd. | James Keyes | 10.21M | 5.1% | SCHEDULE 13D/A ↗ |
| Oct 29, 2026 | SCHEDULE 13D/A (amended) | NNDM Nano Dimension Ltd. | EOM Management Ltd. | 10.21M | 5.1% | SCHEDULE 13D/A ↗ |
| Oct 29, 2026 | SCHEDULE 13D/A (amended) | NNDM Nano Dimension Ltd. | BPY Ltd. | 4.07M | 2.0% | SCHEDULE 13D/A ↗ |
| Oct 29, 2026 | SCHEDULE 13D/A (amended) | NNDM Nano Dimension Ltd. | Nomis Bay Ltd. | 6.14M | 3.0% | SCHEDULE 13D/A ↗ |
| Oct 29, 2026 | SCHEDULE 13D/A (amended) | NNDM Nano Dimension Ltd. | Murchinson Ltd. | 20.42M | 10.1% | SCHEDULE 13D/A ↗ |
| Aug 21, 2026 | SCHEDULE 13G | NNDM Nano Dimension Ltd. | Tang Capital Partners IV, Inc | 4.41M | 2.1% | SCHEDULE 13G ↗ |
| Aug 21, 2026 | SCHEDULE 13G | NNDM Nano Dimension Ltd. | Tang Capital Partners III, Inc | 4.41M | 2.1% | SCHEDULE 13G ↗ |
| Aug 21, 2026 | SCHEDULE 13G | NNDM Nano Dimension Ltd. | Tang Capital Partners International, LP | 6.01M | 2.8% | SCHEDULE 13G ↗ |
| Aug 21, 2026 | SCHEDULE 13G | NNDM Nano Dimension Ltd. | Tang Capital Partners, LP | 4.41M | 2.1% | SCHEDULE 13G ↗ |
| Aug 21, 2026 | SCHEDULE 13G | NNDM Nano Dimension Ltd. | Kevin Tang | 19.23M | 9.1% | SCHEDULE 13G ↗ |
| Aug 21, 2026 | SCHEDULE 13G | NNDM Nano Dimension Ltd. | Tang Capital Management, LLC | 19.23M | 9.1% | SCHEDULE 13G ↗ |
| Jul 27, 2026 | SCHEDULE 13D/A (amended) | NNDM Nano Dimension Ltd. | Concentra Biosciences, LLC | 0 | 0.0% | SCHEDULE 13D/A ↗ |
| Jul 27, 2026 | SCHEDULE 13D/A (amended) | NNDM Nano Dimension Ltd. | Tang Capital Partners IV, Inc | 3.83M | 1.8% | SCHEDULE 13D/A ↗ |
| Jul 27, 2026 | SCHEDULE 13D/A (amended) | NNDM Nano Dimension Ltd. | Tang Capital Partners III, Inc | 3.83M | 1.8% | SCHEDULE 13D/A ↗ |
| Jul 27, 2026 | SCHEDULE 13D/A (amended) | NNDM Nano Dimension Ltd. | Tang Capital Partners International, LP | 5.22M | 2.5% | SCHEDULE 13D/A ↗ |
| Jul 27, 2026 | SCHEDULE 13D/A (amended) | NNDM Nano Dimension Ltd. | Tang Capital Partners, LP | 3.83M | 1.8% | SCHEDULE 13D/A ↗ |
| Jul 27, 2026 | SCHEDULE 13D/A (amended) | NNDM Nano Dimension Ltd. | Kevin Tang | 16.72M | 7.9% | SCHEDULE 13D/A ↗ |
| Jul 27, 2026 | SCHEDULE 13D/A (amended) | NNDM Nano Dimension Ltd. | Tang Capital Management, LLC | 16.72M | 7.9% | SCHEDULE 13D/A ↗ |
| Jul 22, 2026 | SCHEDULE 13D/A (amended) | NNDM Nano Dimension Ltd. | Oramed Pharmaceuticals Inc. | 6.88M | 3.3% | SCHEDULE 13D/A ↗ |
| Jul 20, 2026 | SCHEDULE 13D/A (amended) | NNDM Nano Dimension Ltd. | Marc J. Bistricer | 17.14M | 8.1% | SCHEDULE 13D/A ↗ |
| Jul 20, 2026 | SCHEDULE 13D/A (amended) | NNDM Nano Dimension Ltd. | Clarendon Hugh Masters | 8.57M | 4.1% | SCHEDULE 13D/A ↗ |
| Jul 20, 2026 | SCHEDULE 13D/A (amended) | NNDM Nano Dimension Ltd. | Chaja Carlebach | 8.57M | 4.1% | SCHEDULE 13D/A ↗ |
| Jul 20, 2026 | SCHEDULE 13D/A (amended) | NNDM Nano Dimension Ltd. | Jason Jagessar | 8.57M | 4.1% | SCHEDULE 13D/A ↗ |
| Jul 20, 2026 | SCHEDULE 13D/A (amended) | NNDM Nano Dimension Ltd. | James Keyes | 8.57M | 4.1% | SCHEDULE 13D/A ↗ |
| Jul 20, 2026 | SCHEDULE 13D/A (amended) | NNDM Nano Dimension Ltd. | EOM Management Ltd. | 8.57M | 4.1% | SCHEDULE 13D/A ↗ |
| Jul 20, 2026 | SCHEDULE 13D/A (amended) | NNDM Nano Dimension Ltd. | BPY Ltd. | 3.42M | 1.6% | SCHEDULE 13D/A ↗ |
| Jul 20, 2026 | SCHEDULE 13D/A (amended) | NNDM Nano Dimension Ltd. | Nomis Bay Ltd. | 5.15M | 2.4% | SCHEDULE 13D/A ↗ |
| Jul 20, 2026 | SCHEDULE 13D/A (amended) | NNDM Nano Dimension Ltd. | Murchinson Ltd. | 17.14M | 8.1% | SCHEDULE 13D/A ↗ |
| Jun 30, 2026 | SCHEDULE 13D | NNDM Nano Dimension Ltd. | Concentra Biosciences, LLC | 0 | 0.0% | SCHEDULE 13D ↗ |
| Jun 30, 2026 | SCHEDULE 13D | NNDM Nano Dimension Ltd. | Tang Capital Partners IV, Inc | 3.28M | 1.6% | SCHEDULE 13D ↗ |
| Jun 30, 2026 | SCHEDULE 13D | NNDM Nano Dimension Ltd. | Tang Capital Partners III, Inc | 3.28M | 1.6% | SCHEDULE 13D ↗ |
| Jun 30, 2026 | SCHEDULE 13D | NNDM Nano Dimension Ltd. | Tang Capital Partners International, LP | 4.47M | 2.0% | SCHEDULE 13D ↗ |
| Jun 30, 2026 | SCHEDULE 13D | NNDM Nano Dimension Ltd. | Tang Capital Partners, LP | 3.28M | 1.6% | SCHEDULE 13D ↗ |
| Jun 30, 2026 | SCHEDULE 13D | NNDM Nano Dimension Ltd. | Kevin Tang | 14.29M | 6.8% | SCHEDULE 13D ↗ |
| Jun 30, 2026 | SCHEDULE 13D | NNDM Nano Dimension Ltd. | Tang Capital Management, LLC | 14.29M | 6.8% | SCHEDULE 13D ↗ |
| Jun 23, 2026 | SCHEDULE 13D/A (amended) | NNDM Nano Dimension Ltd. | Marc J. Bistricer | 20.29M | 9.6% | SCHEDULE 13D/A ↗ |
| Jun 23, 2026 | SCHEDULE 13D/A (amended) | NNDM Nano Dimension Ltd. | Clarendon Hugh Masters | 10.14M | 4.8% | SCHEDULE 13D/A ↗ |
| Jun 23, 2026 | SCHEDULE 13D/A (amended) | NNDM Nano Dimension Ltd. | Chaja Carlebach | 10.14M | 4.8% | SCHEDULE 13D/A ↗ |
| Jun 23, 2026 | SCHEDULE 13D/A (amended) | NNDM Nano Dimension Ltd. | Jason Jagessar | 10.14M | 4.8% | SCHEDULE 13D/A ↗ |
| Jun 23, 2026 | SCHEDULE 13D/A (amended) | NNDM Nano Dimension Ltd. | James Keyes | 10.14M | 4.8% | SCHEDULE 13D/A ↗ |
| Jun 23, 2026 | SCHEDULE 13D/A (amended) | NNDM Nano Dimension Ltd. | EOM Management Ltd. | 10.14M | 4.8% | SCHEDULE 13D/A ↗ |
| Jun 23, 2026 | SCHEDULE 13D/A (amended) | NNDM Nano Dimension Ltd. | BPY Ltd. | 4.05M | 1.9% | SCHEDULE 13D/A ↗ |
| Jun 23, 2026 | SCHEDULE 13D/A (amended) | NNDM Nano Dimension Ltd. | Nomis Bay Ltd. | 6.09M | 2.9% | SCHEDULE 13D/A ↗ |
| Jun 23, 2026 | SCHEDULE 13D/A (amended) | NNDM Nano Dimension Ltd. | Murchinson Ltd. | 20.29M | 9.6% | SCHEDULE 13D/A ↗ |
| Jun 17, 2026 | SCHEDULE 13D/A (amended) | NNDM Nano Dimension Ltd. | Oramed Pharmaceuticals Inc. | 15.08M | 7.2% | SCHEDULE 13D/A ↗ |
| May 21, 2026 | SCHEDULE 13D/A (amended) | NNDM Nano Dimension Ltd. | Marc J. Bistricer | 15.55M | 7.4% | SCHEDULE 13D/A ↗ |
Full history on every feed is part of Premium. Premium loads older rows, up to 10,000, and CSV downloads.
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:30 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances